Request for Covid-19 Impact Assessment of this Report

Healthcare

Blood Component Utilization Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • 99S4140993
  • 116 Pages
  • December 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology

Chapter 2: Global Industry Summary

Chapter 3: Market Dynamics

Chapter 4: Global Market Segmentation by region, type and End-Use

Chapter 5: North America Market Segmentation by region, type and End-Use

Chapter 6: Europe Market Segmentation by region, type and End-Use

Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use

Chapter 8: South America Market Segmentation by region, type and End-Use

Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.

Chapter 10: Market Competition by Companies

Chapter 11: Market forecast and environment forecast.

Chapter 12: Industry Summary.

The global Blood Component Utilization market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Blood Component Utilization market segmented into

Platelets 

Plasma 

Red Blood Cells

Based on the end-use, the global Blood Component Utilization market classified into

Symptomatic Anemia in an Euvolemic Patient 

Acute Blood 

Others

Based on geography, the global Blood Component Utilization market segmented into

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are

Johns Hopkins Hospital 

Massachusetts General Hospital 

Mayo Clinic 

Cleveland Clinic 

UCLA Medical Center 

New York-Presbyterian University Hospital 

UCSF Medical Center 

Brigham and Women's Hospital 

University of Michigan Hospitals and Health Centers 

Indiana University Health 

Hospital of the University of Pennsylvania 

Northwestern Memorial Hospital 

NYU Langone Medical Center 

UPMC- University of Pittsburgh Medical Center 

Ronald Reagan UCLA Medical Center 

Nicklaus Children's Hospital 

UF Health Cancer Center at Orlando Health 

All Children's Hospital

Table of Contents

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL BLOOD COMPONENT UTILIZATION INDUSTRY

2.1 Summary about Blood Component Utilization Industry

2.2 Blood Component Utilization Market Trends

2.2.1 Blood Component Utilization Production & Consumption Trends

2.2.2 Blood Component Utilization Demand Structure Trends

2.3 Blood Component Utilization Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Platelets 

4.2.2 Plasma 

4.2.3 Red Blood Cells

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Symptomatic Anemia in an Euvolemic Patient 

4.3.2 Acute Blood 

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Platelets 

5.2.2 Plasma 

5.2.3 Red Blood Cells

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Symptomatic Anemia in an Euvolemic Patient 

5.3.2 Acute Blood 

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Platelets 

6.2.2 Plasma 

6.2.3 Red Blood Cells

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Symptomatic Anemia in an Euvolemic Patient 

6.3.2 Acute Blood 

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Platelets 

7.2.2 Plasma 

7.2.3 Red Blood Cells

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Symptomatic Anemia in an Euvolemic Patient 

7.3.2 Acute Blood 

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Platelets 

8.2.2 Plasma 

8.2.3 Red Blood Cells

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Symptomatic Anemia in an Euvolemic Patient 

8.3.2 Acute Blood 

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Platelets 

9.2.2 Plasma 

9.2.3 Red Blood Cells

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Symptomatic Anemia in an Euvolemic Patient 

9.3.2 Acute Blood 

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Johns Hopkins Hospital 

10.1.2 Massachusetts General Hospital 

10.1.3 Mayo Clinic 

10.1.4 Cleveland Clinic 

10.1.5 UCLA Medical Center 

10.1.6 New York-Presbyterian University Hospital 

10.1.7 UCSF Medical Center 

10.1.8 Brigham and Women's Hospital 

10.1.9 University of Michigan Hospitals and Health Centers 

10.1.10 Indiana University Health 

10.1.11 Hospital of the University of Pennsylvania 

10.1.12 Northwestern Memorial Hospital 

10.1.13 NYU Langone Medical Center 

10.1.14 UPMC- University of Pittsburgh Medical Center 

10.1.15 Ronald Reagan UCLA Medical Center 

10.1.16 Nicklaus Children's Hospital 

10.1.17 UF Health Cancer Center at Orlando Health 

10.1.18 All Children's Hospital

10.2 Blood Component Utilization Sales Date of Major Players (2017-2020e)

10.2.1 Johns Hopkins Hospital 

10.2.2 Massachusetts General Hospital 

10.2.3 Mayo Clinic 

10.2.4 Cleveland Clinic 

10.2.5 UCLA Medical Center 

10.2.6 New York-Presbyterian University Hospital 

10.2.7 UCSF Medical Center 

10.2.8 Brigham and Women's Hospital 

10.2.9 University of Michigan Hospitals and Health Centers 

10.2.10 Indiana University Health 

10.2.11 Hospital of the University of Pennsylvania 

10.2.12 Northwestern Memorial Hospital 

10.2.13 NYU Langone Medical Center 

10.2.14 UPMC- University of Pittsburgh Medical Center 

10.2.15 Ronald Reagan UCLA Medical Center 

10.2.16 Nicklaus Children's Hospital 

10.2.17 UF Health Cancer Center at Orlando Health 

10.2.18 All Children's Hospital

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

List of Table

Table Blood Component Utilization Product Type Overview

Table Blood Component Utilization Product Type Market Share List

Table Blood Component Utilization Product Type of Major Players

Table Brief Introduction of Johns Hopkins Hospital 

Table Brief Introduction of Massachusetts General Hospital 

Table Brief Introduction of Mayo Clinic 

Table Brief Introduction of Cleveland Clinic 

Table Brief Introduction of UCLA Medical Center 

Table Brief Introduction of New York-Presbyterian University Hospital 

Table Brief Introduction of UCSF Medical Center 

Table Brief Introduction of Brigham and Women's Hospital 

Table Brief Introduction of University of Michigan Hospitals and Health Centers 

Table Brief Introduction of Indiana University Health 

Table Brief Introduction of Hospital of the University of Pennsylvania 

Table Brief Introduction of Northwestern Memorial Hospital 

Table Brief Introduction of NYU Langone Medical Center 

Table Brief Introduction of UPMC- University of Pittsburgh Medical Center 

Table Brief Introduction of Ronald Reagan UCLA Medical Center 

Table Brief Introduction of Nicklaus Children's Hospital 

Table Brief Introduction of UF Health Cancer Center at Orlando Health 

Table Brief Introduction of All Children's Hospital

Table Products & Services of Johns Hopkins Hospital 

Table Products & Services of Massachusetts General Hospital 

Table Products & Services of Mayo Clinic 

Table Products & Services of Cleveland Clinic 

Table Products & Services of UCLA Medical Center 

Table Products & Services of New York-Presbyterian University Hospital 

Table Products & Services of UCSF Medical Center 

Table Products & Services of Brigham and Women's Hospital 

Table Products & Services of University of Michigan Hospitals and Health Centers 

Table Products & Services of Indiana University Health 

Table Products & Services of Hospital of the University of Pennsylvania 

Table Products & Services of Northwestern Memorial Hospital 

Table Products & Services of NYU Langone Medical Center 

Table Products & Services of UPMC- University of Pittsburgh Medical Center 

Table Products & Services of Ronald Reagan UCLA Medical Center 

Table Products & Services of Nicklaus Children's Hospital 

Table Products & Services of UF Health Cancer Center at Orlando Health 

Table Products & Services of All Children's Hospital

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Blood Component Utilization Market Forecast (Million USD) by Region 2021f-2026f

Table Global Blood Component Utilization Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Blood Component Utilization Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Blood Component Utilization Market Forecast (Million USD) Share by Demand 2021f-2026f

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950